These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36721043)

  • 21. Phenotypical diversity of airway morphology in chronic lung graft vs. host disease after stem cell transplantation.
    Verleden SE; McDonough JE; Schoemans H; Knoop C; Verschakelen J; Dubbeldam A; Boone MN; Van Hoorebeke L; Verbeken E; Weynand B; Van Raemdonck D; Verleden GM; Vos R; Vanaudenaerde BM
    Mod Pathol; 2019 Jun; 32(6):817-829. PubMed ID: 30723292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Impact of Beta-Blocker Use at the Time of Hematopoietic Cell Transplantation on the Development of Acute and Chronic Graft-Versus-Host Disease.
    Patel A; Murthy GSG; Hamadani M; Szabo A; Knight JM
    Hematol Oncol Stem Cell Ther; 2023 Apr; 16(3):209-216. PubMed ID: 34780786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Graft-Versus-Host Disease: an Update on Functional Implications and Rehabilitation Interventions.
    Brothers L; Malhotra J; Andrews C; Smith SR
    Curr Oncol Rep; 2023 Mar; 25(3):145-150. PubMed ID: 36680673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The frequencies of lymphocyte subsets on "day 30″ correlate with the clinical outcome of pediatric hematopoietic stem cell transplantation.
    Yao Y; Li B; Li J; Yao D; Ling J; Hu Y; Fan L; Wan L; Kong L; Xiao P; Lu J; Meng L; Li Z; Hu S; Tian Y
    Immunol Lett; 2023 Feb; 254():21-29. PubMed ID: 36706923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inferences for current chronic graft-versus-host-disease free and relapse free survival.
    Zhang X; Solomon SR; Sizemore C
    BMC Med Res Methodol; 2022 Dec; 22(1):318. PubMed ID: 36513966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Day 4 collection of granulocyte colony-stimulating factor-mobilized HLA-matched sibling donor peripheral blood allografts demonstrates no long-term increase in chronic graft-versus-host disease or relapse rates.
    Booth G; Yu Y; Harlan RP; Jacoby CE; Tomic KM; Slater SE; Allen BE; Berklich EM; Knight RJ; Dela Cruz J; Fu R; Gandhi A; Cook RJ; Meyers G; Maziarz RT; Newell LF
    Cytotherapy; 2023 Apr; 25(4):423-431. PubMed ID: 36690537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic Graft-versus-host Disease-associated Membranous Nephropathy Following Bone Marrow Transplantation, Successfully Treated with Rituximab.
    Sakai T; Uchida T; Iwama S; Sugisaki K; Yamada M; Inamoto Y; Oda T
    Intern Med; 2023 Jan; 62(2):269-273. PubMed ID: 35732451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lung Transplantation for Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-center Experience.
    Shitenberg D; Pertzov B; Heching M; Shostak Y; Shtraichman O; Rosengarten D; Yeshurun M; Peysakhovich Y; Barac Y; Kramer MR
    Isr Med Assoc J; 2023 Mar; 25(3):227-232. PubMed ID: 36946670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spontaneous pneumothorax developed in patients with bronchiolitis obliterans after unrelated hematopoietic stem cell transplantation: case report and review of the literature.
    Shin HJ; Park CY; Park YH; Kim YJ; Min CK; Lee S; Kim DW; Lee JW; Min WS; Kim CC
    Int J Hematol; 2004 Apr; 79(3):298-302. PubMed ID: 15168602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Multiparameter Prognostic Risk Score of Chronic Graft-versus-Host Disease Based on CXCL10 and Plasmacytoid Dendritic Cell Levels in the Peripheral Blood at 3 Months after Allogeneic Hematopoietic Stem Cell Transplantation.
    Chirumbolo G; Dicataldo M; Barone M; Storci G; De Matteis S; Laprovitera N; Sinigaglia B; Barbato F; Maffini E; Cavo M; Bonifazi F; Arpinati M
    Transplant Cell Ther; 2023 May; 29(5):302.e1-302.e8. PubMed ID: 36796518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Defibrotide impact on the acute GVHD disease incidence in pediatric hematopoietic stem cell transplant recipients.
    Squillaci D; Marcuzzi A; Rimondi E; Riccio G; Barbi E; Zanon D; Maximova N
    Life Sci Alliance; 2023 May; 6(5):. PubMed ID: 36878639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lung transplantation for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: a single-center experience.
    Vogl UM; Nagayama K; Bojic M; Hoda MA; Klepetko W; Jaksch P; Dekan S; Siersch V; Mitterbauer M; Schellongowski P; Greinix HT; Petkov V; Schulenburg A; Kalhs P; Rabitsch W
    Transplantation; 2013 Feb; 95(4):623-8. PubMed ID: 23274967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adults.
    Mehta RS; Peffault de Latour R; DeFor TE; Robin M; Lazaryan A; Xhaard A; Bejanyan N; de Fontbrune FS; Arora M; Brunstein CG; Blazar BR; Weisdorf DJ; MacMillan ML; Socie G; Holtan SG
    Haematologica; 2016 Jun; 101(6):764-72. PubMed ID: 27036159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk Factors for Bronchiolitis Obliterans Syndrome after Initial Detection of Pulmonary Impairment after Hematopoietic Cell Transplantation.
    Alkhunaizi M; Patel B; Bueno L; Bhan N; Ahmed T; Arain MH; Saliba R; Rondon G; Dickey BF; Bashoura L; Ost DE; Li L; Wang S; Shpall E; Champlin RE; Mehta R; Popat UR; Hosing C; Alousi AM; Sheshadri A
    Transplant Cell Ther; 2023 Mar; 29(3):204.e1-204.e7. PubMed ID: 36503180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An uncommon presentation of paediatric chronic graft-versus-host disease after umbilical cord blood transplantation: True lichen planus-like lesions.
    Hsu TJ; Wong LS
    Indian J Dermatol Venereol Leprol; 2023; 89(1):160. PubMed ID: 35962492
    [No Abstract]   [Full Text] [Related]  

  • 36. Regarding chronic graft-versus-host disease in children and adolescents with thalassemia after hematopoietic stem cell transplantation.
    Janowiak-Majeranowska A; Majeranowski A
    Int J Hematol; 2021 Jul; 114(1):147-148. PubMed ID: 33704664
    [No Abstract]   [Full Text] [Related]  

  • 37. Inert Gas Washout in Bronchiolitis Obliterans Following Hematopoietic Cell Transplantation.
    Nyilas S; Baumeler L; Tamm M; Halter JP; Savic S; Korten I; Meyer A; Singer F; Passweg JR; Latzin P; Stolz D
    Chest; 2018 Jul; 154(1):157-168. PubMed ID: 29275133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Favorable impact of natural killer cell reconstitution on chronic graft-versus-host disease and cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation.
    Kheav VD; Busson M; Scieux C; Peffault de Latour R; Maki G; Haas P; Mazeron MC; Carmagnat M; Masson E; Xhaard A; Robin M; Ribaud P; Dulphy N; Loiseau P; Charron D; Socié G; Toubert A; Moins-Teisserenc H
    Haematologica; 2014 Dec; 99(12):1860-7. PubMed ID: 25085354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and economic burden associated with graft-versus-host disease following allogeneic hematopoietic cell transplantation in France.
    Michonneau D; Quignot N; Jiang H; Reichenbach D; Kelly M; Burrell A; Zhang X; Thiruvillakkat K; Mohty M
    Bone Marrow Transplant; 2023 May; 58(5):514-525. PubMed ID: 36765178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteomic Characterization Reveals That MMP-3 Correlates With Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Cell and Lung Transplantation.
    Liu X; Yue Z; Yu J; Daguindau E; Kushekhar K; Zhang Q; Ogata Y; Gafken PR; Inamoto Y; Gracon A; Wilkes DS; Hansen JA; Lee SJ; Chen JY; Paczesny S
    Am J Transplant; 2016 Aug; 16(8):2342-51. PubMed ID: 26887344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.